Since recombinant clotting factors are not derived from blood or plasma , they present a minimal risk of pathogen transmission ( particularly third generation factors , which have no contact with blood / plasma - derived components whatsoever ) and can therefore be considered safer than using plasma - derived clotting factor concentrates [ 11 ] .